These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 34076983)
1. EZH2-mediated long-chain non-coding RNA LINC00963 promotes proliferation and invasion of glioma cells through inhibiting p21 expression. Gai Q; Guo W; Liu J J BUON; 2021; 26(2):380-387. PubMed ID: 34076983 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression. Cheng C; Dong Y; Ru X; Xia Y; Ji Y Cancer Gene Ther; 2021 Sep; 28(9):1025-1034. PubMed ID: 33293663 [TBL] [Abstract][Full Text] [Related]
3. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer. Liu JQ; Feng YH; Zeng S; Zhong MZ Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854 [TBL] [Abstract][Full Text] [Related]
4. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells. Xu C; He T; Li Z; Liu H; Ding B Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2. Yang A; Wang H; Yang X Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366 [TBL] [Abstract][Full Text] [Related]
6. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1. Luo L; Chen C; He H; Cai M; Ling C Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640 [TBL] [Abstract][Full Text] [Related]
7. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p. Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438 [TBL] [Abstract][Full Text] [Related]
8. lncRNA SNHG16 Exerts Oncogenic Functions in Promoting Proliferation of Glioma Through Suppressing p21. Zhou XY; Liu H; Ding ZB; Xi HP; Wang GW Pathol Oncol Res; 2020 Apr; 26(2):1021-1028. PubMed ID: 30972632 [TBL] [Abstract][Full Text] [Related]
9. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis. Cheng T; Xu Y Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602 [TBL] [Abstract][Full Text] [Related]
10. LINC00467 promotes proliferation and invasion in glioma via interacting with miRNA-485-5p. Jiang XH; Liu YY Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):766-772. PubMed ID: 32016980 [TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21. Fei F; He Y; He S; He Z; Wang Y; Wu G; Li M Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30042166 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL. Yan J; Xu C; Li Y; Tang B; Xie S; Hong T; Zeng E J Cell Mol Med; 2019 Aug; 23(8):5518-5531. PubMed ID: 31240814 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2. Zhang B; Fan DB; Liu L; Qin Y; Feng DQ Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6533-6539. PubMed ID: 32633340 [TBL] [Abstract][Full Text] [Related]
14. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2. Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375 [TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma. Meng XF; Zhao LY; Chu XF Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752 [TBL] [Abstract][Full Text] [Related]
16. Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis. Zhang H; Wang Z; Qiao X; Peng N; Wu J; Chen Y; Cheng C Mol Med; 2024 Jun; 30(1):91. PubMed ID: 38886655 [TBL] [Abstract][Full Text] [Related]
17. Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity. Gao F; Du Y; Zhang Y; Ren D; Xu J; Chen D Gene; 2020 Feb; 726():144196. PubMed ID: 31669648 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells. Guo H; Hu G; Yang Q; Zhang P; Kuang W; Zhu X; Wu L Oncotarget; 2016 Dec; 7(49):81806-81814. PubMed ID: 27833083 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells. Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway. Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]